Cellcolabs
About
What does Cellcolabs do?
Cellcolabs produces GMP-certified mesenchymal stem cells (MSCs) in Sweden, supporting clinical research and global collaborations. They offer bone-marrow-derived MSCs that are cryopreserved, genetically stable, and antibiotic-free, manufactured under the oversight of the Swedish Medical Products Agency. Cellcolabs aims to make high-quality stem cells available at an industrial scale for advanced cell therapies.
What is Cellcolabs's revenue?
StartupHub estimates Cellcolabs's annual revenue at $17.3M (range $9.4M to $40.0M, 65% confidence), based on comparable companies in the sector.
What is Cellcolabs's valuation?
StartupHub estimates Cellcolabs's effective valuation at $63.5M (range $38.8M to $93.0M, 19% confidence), based on comparable companies in the sector.
How much funding has Cellcolabs raised?
Cellcolabs has raised a total of $16M in funding.
Where is Cellcolabs headquartered?
Cellcolabs is headquartered in Tel Aviv, Israel.
When was Cellcolabs founded?
Cellcolabs was founded in 2021.
What industry does Cellcolabs operate in?
Cellcolabs operates in Biotech, MedTech, HealthTech, Drug Discovery, AI-Driven Protein Design, Cellular Agriculture.
How many employees does Cellcolabs have?
Cellcolabs has approximately 79 people on record.
No comments yet. Be the first to share your take.